Alexis Practical Tactical ETF LEXI 深 沪
等待开盘 10-16 09:30:00 美东时间
35.105
+0.158
+0.45%
华盛通- 最 高35.28
- 今 开35.2717
- 成交量 5580股
- 最 低 35.08
- 昨 收 34.9469
- 总市值 1.31亿
- 52周最高 35.28
- 市盈率 静 --
- 换手率 0.15%
- 52周最低 26.055
- 委 比 3.23%
- 总股本 372.68万
- 历史最高 35.28
- 量 比 0.45
- 振 幅 0.57%
- 历史最低 19.983
- 每 手 1
- 风险率 1.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ramaco Approved to Join the Defense Industrial Base Consortium (DIBC)
LEXINGTON, Ky., Oct. 15, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB) ("Ramaco" or the "Company") Ramaco, a leading developer of rare earth elements and critical mineral...
10-15 20:45
Martin van Wyk to Join Ramaco in Critical Minerals Leadership Role
LEXINGTON, Ky., Oct. 6, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB) ("Ramaco" or the "Company") Ramaco is proud to announce Martin van Wyk has agreed to join Ramaco as ...
10-06 20:00
Jessica Graney Appointed to Ramaco Foundation Board
LEXINGTON, Ky., Oct. 1, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB, "Ramaco" or the "Company") Ramaco is pleased to announce the appointment of Jessica Graney to the Ra...
10-01 20:00
Ramaco Announces New Senior Management Hire
LEXINGTON, Ky., Sept. 18, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB, "Ramaco" or the "Company") Ramaco is pleased to announce that it has hired Joseph M. Stopper as Se...
09-18 20:04
Ramaco Resources Announces Third Quarter Class B Stock Dividend Details
LEXINGTON, Ky., Sept. 8, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB, "Ramaco" or the "Company") a leading operator and developer of high-quality, low-cost metallurgical...
09-09 04:05
Lexicon Pharmaceuticals to Participate at Two Upcoming Investor Conferences
Lexicon Pharmaceuticals, Inc. announced that its management will participate in fireside chats at Citi's Biopharma Back to School Conference on September 3 at 1:45 p.m. ET and at the H.C. Wainwright Global Investment Conference on September 8 at 3:00 p.m. ET. The live events and replays can be accessed via the Company’s website. Lexicon, a biopharmaceutical company, focuses on pioneering medicines through its Genome5000 program, targeting disease...
08-27 12:30
Keros Therapeutics Reveals The FDA Granted Orphan Drug Designation For KER-065 For The Treatment Of Duchenne Muscular Dystrophy
LEXINGTON, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros") (NASDAQ:KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a
08-20 21:50
Keros Therapeutics Announces Strategic Realignment To Reallocate Resources Towards Development Of Its Key Clinical Program, KER-065; Discontinues Development of Cibotercept (KER-012)
Company Discontinuing Development of Cibotercept (KER-012)Announces Board and Leadership Changes Designed to Support Streamlined Operational Structureand Strategic RealignmentLEXINGTON, Mass., Aug. 06, 2025 (GLOBE
08-07 04:59
Valvoline Inc. Reports Third Quarter Results
Delivers sales of $439 million with strong profit growth; Adds 46 new stores LEXINGTON, Ky., Aug. 6, 2025 /PRNewswire/ -- Valvoline Inc. (NYSE: VVV), the quick, easy, trusted leader in prev...
08-06 19:00
Curis Provides Second Quarter 2025 Business Update
Management to host conference call and webcast today at 8:30 a.m. ET LEXINGTON, Mass., Aug. 5, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the develop...
08-05 20:00
